Previous Article | Next Article ![]()
Journal of Bacteriology, June 2005, p. 4245-4256, Vol. 187, No. 12
0021-9193/05/$08.00+0 doi:10.1128/JB.187.12.4245-4256.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Doniel Astor,1
Robert G. Kranz,2 and
Fevzi Daldal1*
Department of Biology, Plant Science Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104,1 Department of Biology, Washington University, St. Louis, Missouri 631302
Received 12 January 2005/ Accepted 11 March 2005
|
|
|---|
|
|
|---|
![]() View larger version (35K): [in a new window] |
FIG. 1. Current model of Cyt c biogenesis in R. capsulatus. Pre-apo-Cyt c produced in the cytoplasm are translocated across the membrane via the Sec-dependent secretory pathway. Their signal peptides (SP) are either processed or used as N-terminal membrane anchors. Disulfide bonds are assumed to be formed within the cysteines of the conserved apo-Cyt c heme binding motif CxxCH and then possibly chaperoned via CcmI to the Cyt c maturation site. CcdA shuttles electrons across the membrane to the thioreduction component CcmHRc via CcmG. CcmHRc is thought to reduce the heme binding site disulfides prior to heme attachment. The heme cofactor (H) is synthesized in the cytoplasm from -amino levulinic acid ( -ALA), putatively transported to the periplasm via the ATP-binding cassette (ABC) transporter CcmAB, and covalently ligated to CcmE via CcmCD, with WWD referring to the putative heme binding motif. CcmE is postulated to provide the heme to the putative heme lyase component CcmF, which is believed to attach it covalently and stereospecifically to the reduced apo-Cyt c. According to this model, CcmI-null mutants are not able to produce any holo-Cyt c, because apo-Cyt c is not delivered efficiently to the maturation site, as they probably are degraded rapidly. Hence, overproduction of CcmF and CcmHRc can alleviate the need for apo-Cyt c chaperoning and protection function of CcmI. Arrows refer to electron (e-) transfer steps, and ? indicates hypothetical steps. The bottom portion depicts the proposed interactions between CcmI, CcmG, CcmF, CcmHRc and CcmE, forming a hypothetical Cyt c biogenesis "core complex" in Rhodobacter capsulatus. This model proposes that apo-Cyt c interacts with CcmI as part of a multisubunit protein complex including CcmF and CcmHRc.
|
-naphthol + dimethylphenylenediamine
indophenol blue + H2O) reaction (32), Thus, R. capsulatus mutants unable to form c-type holo-Cyts can be identified by their Ps/Nadi dual phenotype (34), via which essential components of Cyt c biogenesis have been identified in this species (Fig. 1, top) (4, 5, 7, 15, 26, 38). As in Escherichia coli, the CcmABCD (also called HelABCD) components form an ATP-binding cassette (ABC)-containing transporter complex, thought to be involved in the export of the heme cofactor across the cytoplasmic membrane. The exported heme binds to CcmE (also called CycJ) (54), which conveys it to the putative apo-Cyt c heme lyase component CcmF (also called Ccl1) (25-27). Unlike E. coli, R. capsulatus and some other species contain two additional components: CcmI (also called CycH), which is proposed to chaperone the c-type apo-Cyts to the maturation site following their translocation to the periplasm (5, 38), and a membrane-bound thioredoxin, designated here as CcmHRc (also called Ccl2), which is involved in the apo-Cyt c thioreduction pathway (4, 5). In E. coli, the carboxyl-terminal part of CcmI is fused to the homologue of CcmHRc to form CcmH (35, 43, 59) (referred to as CcmHEc here). As disulfide bonds are formed in the periplasm between the cysteines of translocated proteins via the DsbA/DsbB pathway for oxidative protein folding (11, 29), similar bonds are also assumed to be built between the heme binding cysteine thiols (39, 40, 50, 51). For periplasmic disulfide reduction, electrons originating from TrxA are thought to be shuttled across the cytoplasmic membrane via CcdA (homologous to the central domain of E. coli DsbD) to CcmG (also called HelX) and then to CcmHRc or CcmHEc depending on the species. The disulfide bonds at the heme binding sites of the c-type apo-Cyts are then believed to be reduced by CcmHRc (or CcmHEc) prior to covalent and stereo-specific heme ligation (Fig. 1, top) (15, 21-23, 30, 41, 44, 48, 56).
In R. capsulatus, CcmI is thought to act as a chaperone that delivers apo-Cyts to the maturation sites (38). Its sequence analysis indicates that it is a bipartite membrane protein that contains two amino-terminal transmembrane helices and a large periplasmic carboxyl-terminal extension of over 300 amino acids (38), designated CcmI-1 and CcmI-2, respectively. In R. capsulatus CcmI mutants lacking the CcmI-2 domain, c-type Cyt maturation becomes growth medium dependent. For example, they can still produce several c-type Cyts (e.g., Cyt c1, cp, and co) during growth in minimal medium but only Cyt c1, which is a subunit of the Cyt bc1 complex (14), in minimal and enriched media, indicating that CcmI-2 is not required for its maturation (38). Interestingly, E. coli, which does not contain a Cyt c1 homologue, naturally lacks an equivalent of CcmI-1.
Our previous analysis of Ps+/Nadi+ revertants of R. capsulatus CcmI-null mutants, such as MT-SRP1.r1, indicated that overexpression of ccmFHRc can bypass the function of CcmI during c-type Cyt maturation on minimal, but not on enriched, medium (16). Remarkably, these mutants can become fully proficient for Cyt c maturation on both media upon acquisition of additional mutations. In this work, we demonstrate that, in addition to the overexpression of ccmFHRc, either overexpression of ccmG or hyperexpression of ccmFHRc is required to fully overcome the role of CcmI in minimal and enriched growth media. These findings indicate that, in the absence of CcmI, interactions between the thioreduction and heme ligation components become restricted, limiting adequate c-type Cyt production. Therefore, although CcmI is not essential for the attachment of the heme cofactor per se, it is an important component for sufficient holo-Cyt c formation under Res and Ps growth on minimal and enriched media.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Molecular genetic techniques.
Standard molecular genetic techniques were performed as described by Sambrook and Russell (52). Conjugal transfer of plasmids from E. coli to R. capsulatus was performed as described previously (12). The R. capsulatus strain MT-SRP1.r1big was grown under Ps conditions on enriched medium and its chromosomal DNA isolated by using the QIAGEN DNeasy kit (Valencia, CA). A genomic library was prepared as described previously (16, 17) by digesting chromosomal DNA with EcoRI and cloning the resulting fragments into the broad-host-range vector pRK415 (19). A 280-bp PCR product containing ccmD was amplified by using the primers helD-Fwd (5'-GCT CTA GAA CCG AGA TCC GCG CCC GTC G-3') and helD-Rev (5'-GGG GTA CCC CCG CGC CAA CAA AGC CCG C-3') carrying the recognition sites for the restriction enzymes XbaI and KpnI at their 5' ends and was then cloned into the respective sites of pRK415 and pCHB500 to yield pCS1526 and pCS1527, respectively. Similarly, pCS1530 was constructed by PCR amplification of an 830-bp fragment containing ccmC using the primers helC2 (5'-CTT ATT CTA GAT TGA TGC GAG TC-3') and helC3 (5'-GAC GCA AGG TAC CTG ACG GCG TAT TTT C-3'); pCS1531 was constructed by PCR amplification of a 1,010-bp fragment containing ccmCD using the primers helC2 and helD-Rev; pCS1532 was constructed by PCR amplification of a 1,490-bp fragment containing ccmCDG using the primers helC2 and RchelX1 (5'-GGC CCC GGT ACC AAG ACG CAG GAT-3'); and pCS1538 was constructed by PCR amplification of a 960-bp fragment containing ubiE::ccmC using the primers helC1 (5'-GAC AGT TCT AGA TCG GCA AGG GCA G-3') and helC3 following appropriate restriction digestion and ligation of the amplified DNA fragments into pRK415. For the construction of pCS1540 and pCS1541, a 570-bp PCR product containing ccmG was amplified by using the primers helXforward-XbaI (5'-CGG GTC TAG AAA GCC CAG GAA GAA CGG A-3') and RchelX1, a 750-bp PCR product containing ccmDG was amplified by using the primers helD-Fwd and RchelX1, respectively, and a restriction digestion and ligation procedure similar to that mentioned above was carried out by using the broad-host-range vector pCHB500 (6). For all of these plasmids, MT-SRP1.r1big chromosomal DNA was used as a template. To create pCS1542, a spectinomycin resistance cassette (2.0 kb) from pHP45
-Spec (47) was inserted in reverse orientation into the unique BamHI site of pCS1532 located in ccmC. Plasmid pCS1539 was obtained by cutting pCS1530 at its unique BamHI site and blunting the ends with T4 DNA polymerase before ligation, resulting in a frameshift mutation in ccmC. For construction of pCS1545, both cysteine codons 75 and 78 of ccmG in pCS1540 were mutated to serine codons by using primers HelX-C78Ss (5'-CTT CTG GGC TTC CTG GAG CGC GCC CTG TCG-3') and HelX-C78Sas (5'-ACC CGA CAG GGC GCG CTC CAG GAA GCC CAG-3') following the instructions of the QuikChange XL site-directed mutagenesis kit from Stratagene (La Jolla, CA). All plasmids were verified by DNA sequence analyses using appropriate primers (see below).
DNA sequence analysis. Automated DNA sequencing with the Big-Dye terminator cycle sequencing kit (Applied Biosystems) was performed according to the manufacturer by using the helC2, helC3, M13-forward, and M13-reverse primers to verify all pRK415 and pCHB500 derivatives constructed in this study. Chromosomal DNA of MT1131, MT-SRP1.r1, and MT-SRP1.r1big isolated with the DNeasy kit were used as templates, and the ORF124/ccmABCDG promoter region was amplified using the primers RcORF124down (5'-CTG GCG CTG GTG CCG ATG CTG GAT C-3') and RchelCpromup (5'-CGG CTC TCC TCC CTC TCG CGT CCC G-3') to generate a 2,070-bp PCR product, which was purified by using the QIAGEN PCR purification kit and sequenced using the same primers. Similarly, the 5' region of ccmC including the intergenic space between ccmB and ccmC was amplified by using the same DNA template and the primers helC2 and helC3 to yield an 830-bp PCR fragment, which was purified and sequenced by using the primer helC2. DNA sequence analyses, homology searches, and genome sequence comparisons were done using MacVector (Kodak) and BLAST software packages (3).
Biochemical techniques. Intracytoplasmic membrane vesicles, or chromatophores, were prepared in 20 mM MOPS (morpholinepropanesulfonic acid)-KOH buffer (pH 7.0) containing 1 mM KCl, 10 mM EDTA and a protease inhibitor cocktail (Complete, EDTA-free from Roche Inc., Indianapolis, IN) as recommended by the manufacturer using a French pressure cell (28). Protein concentrations were determined according to the method of Bradford (9) using the stain solution Bio-Safe Coomassie from Bio-Rad (Hercules, CA). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (16.5% T, 6% C) was used as described by Schaegger and von Jagow (53), and various c-type Cyts were revealed via their endogenous peroxidase activity using tetramethylbenzidine (TMBZ) and H2O2 (58). Cyt c oxidase activity of the colonies was detected using the Nadi reaction as described earlier (32). Antisera against CcmA and CcmG were produced, and immunoblot analyses were performed, as described elsewhere (26).
Chemicals. All chemicals were of reagent grade and obtained from commercial sources.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Phenotypes of various CcmI-null mutants and their derivatives
|
![]() View larger version (19K): [in a new window] |
FIG. 2. Plasmids pDA5 and pDA10, which confer the Ps+ growth phenotype on MT-SRP1.r1. The 1.4- and 1.6-kb EcoRI fragments of pDA5 are not contiguous with each other on the R. capsulatus chromosome. The 1.4-kb fragment carries two complete (ccmD and RRC02436[ccmG]) and two incomplete (RRC02435[hpt, hypoxanthine-guanine phosphoribosyltransferase] and RRC02437[ccmC]) ORFs. The 1.6-kb fragment contains two incomplete ORFs, RRC03382(ysiB, putative enoyl-CoA hydratase) and RRC03385(ubiE, ubiquinone/menaquinone biosynthesis methyltransferase). The two EcoRI fragments of pDA10 are also noncontiguous on the R. capsulatus chromosome. The 3.1-kb fragment carries one complete (RRC04065[serC]) and two incomplete (RRC04064[serB] and RRC02911[serA]) ORFs involved in serine biosynthesis. The 13.5-kb fragment contains nine complete ORFs (RRC00283[entB, isochorismatase], RRC00284and RRC00285[argF and argD, respectively, involved in arginine biosynthesis], RRC00286and RRC00287[ccmF and ccmHRc, respectively, encoding the putative apo-Cyt c heme ligation complex CcmF and CcmHRc], RRC00288[fadB, enoyl-CoA hydratase], RRC00289[msbA, ATP binding lipid transporter], RRC00290[acs, acetyl-CoA synthetase], and RRC002361 [cspA, cold shock DNA binding protein]), and three incomplete (RRC00282[hrpB, ATP-dependent helicase], and overlapping RRC00291[miaB, 2-methylthioadenine synthetase] and RRC04574[a putative membrane protein with a possible oxidoreductase function]). The ability of pDA5, pDA10, pCS1536, and pCS1537 to confer on MT-SRP1.r1 a Ps+ phenotype on enriched medium is indicated to the right, E refers to EcoRI cleavage sites, and thick slashes indicate that the ORFs and the intergenic spaces are truncated as needed to fit the figure.
|
![]() View larger version (24K): [in a new window] |
FIG. 3. Comparison of plasmids carrying various alleles of ccmF-ccmHRc. Plasmids pCS1537, pMM401, and pYZ10 carry a ccmF-ccmHRc up-promoter allele, whereas pMM403 has a wild-type ccmF-ccmHRc allele (Table 1). Plasmids pYZ4 and pYZ12 are CcmF CcmHRc+ and CcmF+ CcmHRc derivatives, respectively, of pYZ10. The ability of various plasmids to complement null mutants of CcmF (MD12), CcmHRc (MD14), and CcmI (MT-SRP1.r1) for Ps+ growth on enriched medium is indicated to the right. White arrows with black borders and the gray arrow refer to the promoter-up allele and wild type of ccmF-ccmHRc, respectively, and S, X, K, E, D, A, B, and C refer to cleavage sites of the restriction enzymes SphI, XbaI, KpnI, EcoRI, BclI, SacI, BamHI, and ClaI, respectively.
|
![]() View larger version (53K): [in a new window] |
FIG. 4. c-type Cyt profiles of various pDA10-related Ps+ derivatives of MT-SRP1.r1. Chromatophore membranes were prepared from R. capsulatus strains grown in enriched medium under respiratory condition and subjected to TMBZ SDS-PAGE analyses as described in Materials and Methods. Approximately 75 µg of proteins of strains MT1131 (wild type), MT-SRP1.r1 (CcmI CcmFHRcup), and its derivatives containing pDA10 [p(ccmFHRcup)1], pYZ10 [p(ccmFHRcup)], pYZ4 [p( ccmF ccmHRcup)], and pYZ12 [p(ccmFup ccmHRc)], were loaded in each lane. Their respective Ps growth phenotypes on enriched medium are indicated at the bottom of the figure, and the molecular weight markers (in thousands) are shown on the left.
|
helD) and CcmG-null (SB1003
helX) mutants (Fig. 5). This finding suggested that, although the 1.4-kb fragment (pCS1534) contained expressed wild-type copies of ccmD and ccmG, including a truncated form of ccmC ('ccmC), both of the EcoRI inserts were required for complementation of MT-SRP1.r1 by pDA5. On the other hand, the plasmids p2hel-404 containing ccmABCDG and pCS1532 carrying ccmCDG clusters conferred Ps+ growth ability on MT-SRP1.r1 on enriched medium like pDA5 (Fig. 5, rows 4 and 5). Thus, providing multiple copies of ccmCDG in trans was sufficient to render MT-SRP1.r1 Ps+ on enriched medium.
![]() View larger version (24K): [in a new window] |
FIG. 5. Restriction maps of pDA5 and its derivatives. Plasmid pDA5 carries a ubiE::ccmC fusion in frame spanning the internal EcoRI site joining the 1.6- and 1.4-kb fragments, which are cloned separately to yield pCS1534 and pCS1535, respectively. Plasmids p2hel-404 and pCS1532 carry ccmABCDG and ccmCDG, respectively. pCS1542 and pCS1539 are derivatives of pCS1532 with a ccmC::spe insertion polar on the downstream genes ccmDG and a frameshift mutation in ccmC (ccm CB), respectively. pCS1541, pCS1527 and pCS1540 are derivatives of pCHB500 and express ccmDG, ccmD and ccmG, respectively, via the cycA promoter. The ability of these plasmids to complement the CcmI-null mutant MT-SRP1.r1, the CcmD-null mutant SB1003 helD, the CcmG-null mutant SB1003 helX, and the CcmC-null mutant TCK2 for Ps+ growth on enriched medium is shown on the right. Curved arrows refer to various promoters mediating different levels of expression of downstream genes, as follows. Black arrow, E. coli lacZ promoter; dark gray arrow, ubiE promoter; light gray arrow, promoter downstream of the ccmB and upstream of the EcoRI site in ccmC; white arrow with black border, cycA promoter; gray arrow with black border, promoter downstream of the BamHI site in ccmC and upstream of ccmD). X, K, E, and B refer to cleavage sites of the restriction enzymes XbaI, KpnI, EcoRI, and BamHI, respectively.
|
![]() View larger version (38K): [in a new window] |
FIG. 6. c-type Cyt profiles of various pDA5-related Ps+ derivatives of MT-SRP1.r1. Chromatophore membranes (A and C) and soluble fractions (B) prepared from R. capsulatus strains grown in enriched medium under respiratory conditions were subjected to TMBZ SDS-PAGE analyses, as described in Material and Methods. Approximately 75 µg of proteins was loaded in each lane, and the Ps growth phenotypes on enriched medium of the strains used are indicated at the bottom of the panels B and C. Panels A and B correspond to the membrane and soluble fractions, respectively, of MT1131 (wild type), MT-SRP1.r1 (CcmI CcmFHRcup), MT-SRP1.r1big (CcmI CcmFHRcup BigX) and the MT-SRP1.r1 derivatives containing p2hel-404 [p(ccmABCDG)], pCS1532 [p(ccmCDG)], pDA5 [p(ubiE::ccmCDG)] and pCS1534 [p('ccmC ccmDG)], and panel C corresponds to the membrane fractions of MT1131 (wild type), MT-SRP1.r1 (CcmI CcmFHRcup) and its derivatives carrying pCS1541 [p(ccmDG)], pCS1527 [p(ccmD)], pCS1540 [p(ccmG)], pCS1542 [p(ccmC::spe ccmDG)], and pCS1539 [p(ccm CB ccmDG)], as listed in Table 1. The molecular weight markers (in thousands) are indicated on the left.
|
C) but not pCS1542 containing a polar ccmC::spe insertion (47) was able to restore the Ps+ phenotype of MT-SRP1.r1 on enriched medium (Table 1). Indeed, control experiments indicated that both pCS1539 and pCS1542 complemented appropriate CcmD (SB1003
ccmD) and CcmG (SB1003
ccmG) mutants to Ps+/Nadi+ (Fig. 5, rows 6 and 7). Thus, it was concluded that the complementation seen with pDA5 was due to the ubiE promoter.
Overproduction of ccmG is sufficient for Ps+ growth of MT-SRP1.r1 on enriched medium.
The plasmids pCS1527, pCS1540, and pCS1541, overexpressing ccmD, ccmG, and ccmDG, respectively, via the R. capsulatus cycA promoter, were constructed to probe whether Ps+ growth of MT-SRP1.r1 on enriched medium (Table 1) required either or both of these genes. Upon conjugation into MT-SRP1.r1, both pCS1540 and pCS1541, but not pCS1527, were able to confer Ps+ growth on enriched medium, indicating that overexpression of only ccmG was sufficient for this phenotype (Fig. 5, rows 8 to 10). Appropriate MT-SRP1.r1 (CcmI CcmFHRcup) derivatives were then subjected to immunoblot analyses using polyclonal antibodies against CcmG to confirm that overexpression of ccmG via additional ccmABCDG-endogenous or -exogenous promoters resulted in its overproduction. The amounts of the 18-kDa CcmG protein (41) were indeed higher in the Ps+ derivatives of MT-SRP1.r1 containing pCS1541 (ccmDG), pCS1540 (ccmG) and pCS1539 (ccm
C and ccmDG) and thus overexpressing ccmG via an additional promoter than in the Ps derivatives of the same strain carrying pCS1527 (ccmG) and pCS1542 (ccmC::spe and ccmDG) (Fig. 7A, compare lanes 3, 5, and 7 to 4 and 6). Equally, in chromatophore membranes of MT-SRP1.r1 derivatives carrying p2hel404 (ccmABCDG), pCS1532 (ccmCDG) and pDA5 (ubiE::ccmC and ccmDG) CcmG amounts were higher than those in derivatives harboring pCS1534 ('ccmC and ccmDG) and the wild-type strain MT1131 (Fig. 7B, compare lanes 5 to 7 to 2 and 8), which in turn were higher than those in MT-SRP1.r1 and MT-SRP1.r1big (Fig. 7B, lanes 3 and 4). As a control, the 25-kDa membrane-associated protein CcmA (26) was absent in a CcmA-null mutant (KR319) and not overproduced in MT-SRP1.r1, MT-SRP1.r1big, or MT-SRP1.r1 derivatives carrying additional copies of various portions of the ccmABCDG cluster (i.e., p2hel404, pCS1532, pDA5, or pCS1534) (Fig. 7C). Thus, in all instances, the increased amounts of CcmG correlated with the Ps+ phenotype of MT-SRP1.r1 derivatives, demonstrating that its overproduction in addition to that of CcmF and CcmHRc resulted in restoration of sufficient Cyt c biogenesis in the absence of CcmI.
![]() View larger version (43K): [in a new window] |
FIG. 7. Immunoblot analyses of CcmG and CcmA in MT-SRP1.r1 and its Ps+ derivatives. Chromatophore membranes were prepared from R. capsulatus strains grown in enriched medium under respiratory conditions and subjected to SDS-PAGE, approximately 25 µg of protein was loaded in each lane, and immunoblot analyses using polyclonal antibodies against CcmG (A and B) and CcmA (C) were performed as described in Material and Methods. Strains KR319 (CcmA), MT1131 (wild type), MT-SRP1.r1 (CcmI CcmFHRcup), and MT-SRP1.r1big (CcmI CcmFHRcup BigX) and the MT-SRP1.r1 derivatives harboring p2hel-404 [p(ccmABCDG)], pCS1532 [p(ccmCDG)], pDA5 [p(ubiE::ccmCDG)] and pCS1534 [p('ccmC ccmDG)], pCS1541 [p(ccmDG)], pCS1527 [p(ccmD)], pCS1540 [p(ccmG)], pCS1542 [p(ccmC::spe ccmDG)], pCS1539 [p(ccm CB ccmDG)] and pCS1545 [p(ccmG-C75S/C78S)] were used. Their respective Ps growth phenotypes on enriched medium are indicated at the bottom of panels A and C. Relevant molecular weight markers (in thousands) are also indicated.
|
C and ccmDG) (lanes 3, 5 and 7) than in those containing pCS1527 (ccmD) and pCS1542 (ccmC::spe and ccmDG) (lanes 2, 4, and 6). However, they were still lower than those in the wild-type strain MT1131 (lane 1). To further probe whether the thioredoxin function of CcmG was indeed required for its ability to confer Ps+ growth on MT-SRP1.r1 in minimal and enriched media, its cysteine residues (Cys 75 and Cys 78) were replaced with serines in pCS1540 to yield pCS1545. This cysteineless CcmG derivative (CcmG-C75S/C78S) was unable to support Ps+ growth of MT-SRP1.r1 on enriched media, although it was produced at adequate amounts (Fig. 7A, compare lanes 5 and 8). Thus, the thioredoxin motif of CcmG was necessary for its suppressor ability under the Ps growth conditions tested here.
|
|
|---|
The data obtained also pointed out that the transcriptional organization of the ccmABCDG cluster is complex. In addition to a promoter located upstream of ORF124/ccmA (5), a second promoter located between the stop codon of ccmB and the EcoRI site within ccmC is also present as a plasmid harboring only ccmCDG (Table 1) could render MT-SRP1.r1 Ps+ on enriched media. Moreover, since plasmids containing a polar insertion in ccmC or a fragment carrying a truncated ccmC upstream of intact ccmD and ccmG can complement appropriate CcmD and CcmG mutants as well (Fig. 5) but fail to support Ps+ growth of MT-SRP1.r1 on enriched medium, a third, weaker promoter appears to be located downstream from the BamHI site in ccmC and upstream of ccmD. The presence of a promoter within the ccmABCDG cluster endowing ccmCDG with the ability to be expressed independently of ccmAB raises the possibility that the products of these two clusters could be synthesized in different stoichiometries.
In addition to CcmG overproduction, CcmI mutants containing both chromosomal and plasmid-borne copies of a promoter-up allele of ccmFHRcup cluster (16), hence highly overproducing CcmF and CcmHRc (data not shown), are also proficient for Cyt c maturation in minimal and enriched media. However, the photosynthetic growth of a CcmI mutant carrying a chromosomal wild-type ccmFHRc allele (e.g., MT-SRP1) is much slower (requiring at least 7 days of incubation) than growth of a mutant with a similar promoter-up ccmFHRcup allele (e.g., MT-SRP1.r1). Furthermore, neither of these CcmI mutants could be complemented for Ps+ growth on enriched medium upon introduction of a plasmid-borne wild-type copy of the ccmFHRc cluster (Fig. 3). Thus, a threshold level of CcmF and CcmHRc overproduction appears to be required to overcome the absence of CcmI during Cyt c biogenesis.
The fact that both CcmG and CcmHRc are known to be components of the thioreduction pathway (41), and that the thioredoxin motif of CcmG is required for suppression, raises the possibility that the growth defect of CcmI mutants on enriched medium might be due to a lack of adequate redox power to ensure sufficient holo-Cyt c formation. How the levels of CcmF, CcmHRc, and CcmG are regulated in R. capsulatus is not yet well known. Available data indicate that the amounts of CcmHRc and possibly of CcmF are dramatically increased during Res, compared to Ps, growth conditions, whereas those of CcmG remain almost unchanged. Similarly, the levels of CcmHRc and CcmG are higher in enriched than in minimal medium (24). These findings suggest that, while larger amounts of thioreduction components are required to support both Res and Ps growth in enriched medium, smaller amounts of CcmF and CcmHRc are sufficient under Ps than under Res conditions. Although the amounts of CcmF, CcmHRc and CcmG are regulated depending on the growth conditions, in the absence of CcmI, their levels might need to be adjusted to sustain productive Cyt c biogenesis. However, supplementation of enriched medium neither with different redox-active chemicals nor with the different nutritional constituents of the minimal medium (see Material and Methods) was sufficient to restore the Ps+ phenotype of MT-SRP1.r1. Thus, bypassing the absence of CcmI might not be mediated solely by the increased protein dithiol:disulfide oxidoreductase activities via the overproduction of CcmG and CcmHRc.
Remarkably, suppression of ccmI always requires both CcmF and CcmHRc, as if these two components act together. In E. coli, CcmF, CcmE, and CcmHEc coimmunoprecipitate, suggesting that they might form a heme ligation complex transferring heme from CcmE to apo-Cyt c (49). If a similar situation is also valid in R. capsulatus (16), then comparable interactions between CcmF, CcmHRc, CcmI, and CcmE might be expected (Fig. 1, bottom). Thus, a possibility is that overproduction of CcmG, CcmF, and CcmHRc in the absence of CcmI might enhance more efficient interactions of the remaining components so that adequate thioreduction of, and heme ligation to, the apo-Cyt c substrates can occur. Alternatively, overproduction of CcmF and CcmHRc could increase the capture rate of apo-Cyt c substrates by the heme ligation complex to compete out their proteolysis in the absence of specific protection factors like CcmI, as proposed earlier (16). In E. coli, the formation of specific disulfide intermediates between the thioredoxin motifs of CcmG and CcmHEc, respectively, as well as the heme binding motif of apo-Cyt c and the thioredoxin motif of CcmHEc, has been documented (23, 48). Conceivably, in the absence of CcmI, the rate of these interactions compared to that of apo-Cyt c proteolysis might be limiting.
Recently, it has been shown that expression in trans of the N-terminal transmembrane helix and the adjacent cytoplasmic loop of CcmI-1 is not sufficient for Cyt c maturation but alleviates the protoporphyrin IX (PPIX) accumulation phenotype of CcmI-null mutants in Sinorhizobium meliloti (10). This observation led to the proposal that in the absence of the CcmI-1 region, either heme synthesis via ferrochelatase or heme transport across the membrane is defective, leading to PPIX accumulation. However, the fact that CcmI-null mutants are fully proficient for c-type Cyt biogenesis by overproduction of CcmG in addition to CcmF and CcmHRc, as shown in this work, argues that the main function of CcmI might not be directly related to heme biosynthesis or delivery. It has been reported that CcmF in Paracoccus denitrificans, Pseudomonas putida, and Rhizobium etli, as well as CcmI in the latter species, is required not only for Cyt c maturation but also for siderophore synthesis and iron acquisition (18, 45, 65). In R. etli, CcmF or CcmI mutants also accumulate PPIX (65) raising the possibility that the CcmI-1 homologue of S. meliloti might be specifically involved in these periplasmic processes. Several R. capsulatus Cyt c biogenesis mutants exhibit a similar porphyrin excretion phenotype (7, 15, 26, 36); however, whether CcmI, CcmF and CcmHRc are necessary for iron acquisition in this species remains to be seen.
How CcmI interacts with the c-type apo-Cyts is unknown. Disulfide bonds are thought to be formed within the cysteines of the conserved heme-binding motif of the apo-Cyt c (22), possibly via the DsbA and DsbB components of the periplasmic protein disulfide oxidoreductase pathway (39, 40, 50, 51). However, it is now clear that this thio-oxidative pathway is not essential for Cyt c maturation (1, 17, 20). Nonetheless, when it is present, these bonds may need to be reduced via the thioreduction branch prior to heme attachment (15, 30, 41). It is thus tempting to speculate that CcmI might interact with other Cyt c biogenesis components, such as CcmF, CcmHRc, and CcmG, via the leucine zipper-like domain in CcmI-1 (38), while recognizing the disulfide bond containing c-type apo-Cyt substrates via its tetratricopeptide-like (TPR) motifs in CcmI-2 (10) (Fig. 1), or vice versa. Whereas leucine zipper motifs facilitate dimerization (37, 42), TPR-containing proteins interact with a partner protein(s) in multiprotein complexes (8, 13).
Finally, it should be mentioned that overexpression of ccmG is not the molecular basis of the Ps+ phenotype on enriched medium of the ccmI suppressor MT-SRP1.r1big (Table 2) (which was used to construct the initial chromosomal library), because similar amounts of CcmG are present in chromatophore membranes of MT-SRP1.r1 and MT-SRP1.r1big (Fig. 7B). Moreover, no DNA sequence difference in the 5' upstream promoter region of the ORF124/ccmABCDG cluster or in the ccmB-ccmC intergenic region was found in MT-SRP1.r1big compared to MT-SRP1.r1 (data not shown). Thus, another mutation(s) in a currently unknown component(s), such as periplasmic proteases, might also confer Ps+ growth ability on a CcmI-null mutant.
In summary, it is clear that overproduction of CcmG in addition to that of CcmF and CcmHRc is necessary for full efficiency of Cyt c maturation in the absence of CcmI, suggesting specific interactions between these components. Future analyses of these interactions should provide further insights on the cross-point between the apo-Cyt c delivery and the thioreduction branches of Cyt c biogenesis.
We thank K. Wade for her help during this work and J. W. Cooley for his editorial comments.
Present address: Colgate-Palmolive Inc. Research Center, Piscataway, N.J. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»